News on Dupont %26 Company France from BioPortfolio.com http://www.BioPortfolio.com Consolidated Dupont %26 Company France news from BioPortfolio.com Wed, 10 Feb 2010 00:08:33 GMT en Drought-Tolerant Crops Key to Increasing Ag Phttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032254&HITNO=0&MSIZE=147&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dupont%20%26%20Company%20France&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032254&THISHREF=http://c.moreover.com/click/here.pl%3fz2534567975%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032254&HITNO=0&MSIZE=147&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dupont%20%26%20Company%20France&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032254&THISHREF=http://c.moreover.com/click/here.pl%3fz2534567975%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCheckbiotech: India Rejects Monsanto GMO Seedshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037823&HITNO=1&MSIZE=147&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dupont%20%26%20Company%20France&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037823&THISHREF=http://c.moreover.com/click/here.pl%3fz2537312281%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037823&HITNO=1&MSIZE=147&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dupont%20%26%20Company%20France&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037823&THISHREF=http://c.moreover.com/click/here.pl%3fz2537312281%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comProcessing Magazine: India Rejects Monsanto GMO Seedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036510&HITNO=2&MSIZE=147&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dupont%20%26%20Company%20France&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036510&THISHREF=http://c.moreover.com/click/here.pl%3fz2536639158%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036510&HITNO=2&MSIZE=147&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dupont%20%26%20Company%20France&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036510&THISHREF=http://c.moreover.com/click/here.pl%3fz2536639158%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comProcessing Magazine: Arkema increases Acrylic Acid and Acrylic Esters prices in Europehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035059&HITNO=3&MSIZE=147&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dupont%20%26%20Company%20France&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035059&THISHREF=http://c.moreover.com/click/here.pl%3fz2536104973%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035059&HITNO=3&MSIZE=147&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dupont%20%26%20Company%20France&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035059&THISHREF=http://c.moreover.com/click/here.pl%3fz2536104973%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comChemie.de: Monsantohttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031594&HITNO=4&MSIZE=147&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dupont%20%26%20Company%20France&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031594&THISHREF=http://c.moreover.com/click/here.pl%3fz2534273174%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031594&HITNO=4&MSIZE=147&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dupont%20%26%20Company%20France&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031594&THISHREF=http://c.moreover.com/click/here.pl%3fz2534273174%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGreenpeace USA: Daiichi Sankyo Initiates Largest Single, Double-Blind, Randomized, Phase III Trial for Treatment and Preventiohttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024545&HITNO=5&MSIZE=147&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dupont%20%26%20Company%20France&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024545&THISHREF=http://c.moreover.com/click/here.pl%3fz2528985349%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024545&HITNO=5&MSIZE=147&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dupont%20%26%20Company%20France&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024545&THISHREF=http://c.moreover.com/click/here.pl%3fz2528985349%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Questcor Pharmaceuticals appoints new chief medical officer - Zib...http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4021597&HITNO=6&MSIZE=147&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dupont%20%26%20Company%20France&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4021597&THISHREF=http://c.moreover.com/click/here.pl%3fz2527284968%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4021597&HITNO=6&MSIZE=147&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dupont%20%26%20Company%20France&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4021597&THISHREF=http://c.moreover.com/click/here.pl%3fz2527284968%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comZibb: Pierre Fabre signs license and development agreement with Abbott ...http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4022773&HITNO=7&MSIZE=147&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dupont%20%26%20Company%20France&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4022773&THISHREF=http://c.moreover.com/click/here.pl%3fz2527852785%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4022773&HITNO=7&MSIZE=147&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dupont%20%26%20Company%20France&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4022773&THISHREF=http://c.moreover.com/click/here.pl%3fz2527852785%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comZibb: Emergo Group Acquires UK Medical Device Companyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019333&HITNO=8&MSIZE=147&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dupont%20%26%20Company%20France&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019333&THISHREF=http://c.moreover.com/click/here.pl%3fz2526232154%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019333&HITNO=8&MSIZE=147&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dupont%20%26%20Company%20France&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019333&THISHREF=http://c.moreover.com/click/here.pl%3fz2526232154%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical Device Link: INVO Bioscience Announces a 36% Pregnancy Rate in a 50 Patient Study Presented at the San Salvador Conferencehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4009971&HITNO=9&MSIZE=147&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dupont%20%26%20Company%20France&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4009971&THISHREF=http://c.moreover.com/click/here.pl%3fz2522178797%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4009971&HITNO=9&MSIZE=147&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dupont%20%26%20Company%20France&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4009971&THISHREF=http://c.moreover.com/click/here.pl%3fz2522178797%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comQuote.com France: Paladin Granted Priority Review Status for Abstral by Health Canadahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4014592&HITNO=10&MSIZE=147&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dupont%20%26%20Company%20France&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4014592&THISHREF=http://c.moreover.com/click/here.pl%3fz2524065215%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4014592&HITNO=10&MSIZE=147&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dupont%20%26%20Company%20France&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4014592&THISHREF=http://c.moreover.com/click/here.pl%3fz2524065215%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Daiichi Sankyo Initiates Largest Single, Double-Blind, Randomized, Phase III Trial For Treatment And Prevention Of Recurrent Venous Thromboembolismhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4014300&HITNO=11&MSIZE=147&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dupont%20%26%20Company%20France&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4014300&THISHREF=http://c.moreover.com/click/here.pl%3fz2523958029%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4014300&HITNO=11&MSIZE=147&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dupont%20%26%20Company%20France&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4014300&THISHREF=http://c.moreover.com/click/here.pl%3fz2523958029%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceutical Online: US FDA Warns Eli Lilly and Company (LLY), Sanofi-Aventis (France) (SASY.PA), Meda AB (SE:MEDAa) on Misleadinghttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4014233&HITNO=12&MSIZE=147&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dupont%20%26%20Company%20France&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4014233&THISHREF=http://c.moreover.com/click/here.pl%3fz2523936210%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4014233&HITNO=12&MSIZE=147&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dupont%20%26%20Company%20France&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4014233&THISHREF=http://c.moreover.com/click/here.pl%3fz2523936210%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioSpace: Paladin Granted Priority Review Status for Abstral(R) by Health Canadahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013583&HITNO=13&MSIZE=147&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dupont%20%26%20Company%20France&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013583&THISHREF=http://c.moreover.com/click/here.pl%3fz2523767050%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013583&HITNO=13&MSIZE=147&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dupont%20%26%20Company%20France&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013583&THISHREF=http://c.moreover.com/click/here.pl%3fz2523767050%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Paladin Granted Priority Review Status for Abstral by Health Canadahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4012666&HITNO=14&MSIZE=147&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dupont%20%26%20Company%20France&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4012666&THISHREF=http://c.moreover.com/click/here.pl%3fz2523494595%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4012666&HITNO=14&MSIZE=147&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dupont%20%26%20Company%20France&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4012666&THISHREF=http://c.moreover.com/click/here.pl%3fz2523494595%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: